期刊文献+

环孢素与其3种代谢物的浓度相关性和生物转化的分析 被引量:16

Correlation between cyclosporine A and its metabolites in patients with renal transplantation
下载PDF
导出
摘要 目的:测定患者服用环孢素后全血中环孢素及其代谢物浓度,分析环孢素与其3种代谢物的浓度之间的关系,研究环孢素体内代谢规律。方法:30例肾移植患者口服环孢素后12h采用液相色谱-质谱联用仪测定环孢素与其3种代谢物的全血浓度,采用线性回归法计算环孢素与其3种代谢物的浓度相关系数,评价相关性。结果:环孢素与去甲环孢素、羟化环孢素及二羟化环孢素的相关性逐步递增,相关系数分别为0.5151,0.7887,0.8084。羟化环孢素浓度与二羟化环孢素浓度具有较强的相关性,相关系数为0.8651。结论:测定环孢素及其3种代谢产物不仅是延长移植器官在体生存期,避免肝肾性综合体征反应的一种有效的方法,而且对于个体化用药具有重要意义。 Objective: To monitor the blood concentrations of cyclosporine A (CsA) and its metabolites in patients with renal transplantation to assess their correlation of enzyme metabolism to individual difference. Methods:The blood samples from patients with renal transplantation who orally administrated CsA in 12 hours were measured by liquid chromatography tandem mass spectrometry. The correlation coefficient of the blood concentration of CsA with its metabolites was calculated using the linear regression. Results:The analytic results showed an escalated correlation coefficient of CsA with demethyl CsA, hydroxy CsA and dihydroxy CsA (0.5151,0.788 7,0. 8084), respectively. The concentration of hydroxy CsA was correlated with concentration of dihydroxy CsA (coefficient 0.8651). Conclusion:The CsA metabolites may result in major side effects in patents with renal transplantation. Thus, monitoring the concentrations of CsA and its metabolites may provide clinical preventions for the liver renal adverse reactions and rational regimens in individualized administration of CsA.
出处 《中国新药杂志》 CAS CSCD 北大核心 2005年第1期85-89,共5页 Chinese Journal of New Drugs
基金 国家自然科学基金(30472056)
关键词 环孢素 代谢产物 相关性 生物转化 cyclosporine A metabolite correlation biotransformation
  • 相关文献

参考文献8

  • 1Brozmanova H,Grundann M,Safarcik K, et al. High-performance liquid chromatographic method for therapeutic drug monitoring of cyclosporine A and its two metabolites in renal transplant patients [J] .J Chromatogr B ,2000,749(1) :93 - 100.
  • 2Simpson J, Zhang QL, Ozaeta P, et al. A specific method for mea surement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry [ J ]. Ther Drug Monit,1998,20(3) :294 - 300.
  • 3Douglas B, Chris D, James P, et al. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients [J ]. Transplantation, 2003, 75 (12): 2058 - 2063.
  • 4Altaca G,Berber I,Aydin C, et al. Effect of low-dose calcineurin inhibitors on acute rejection and graft survival [J]. Transplant Proc, 2002,34 (6): 2079 - 2080.
  • 5Shirley MT, Robert ZH, Uwe C, et al. Red wine decreases cyclosporine bioavailability [J ]. Clin Pharm Ther, 2001,70 ( 5 ): 463 - 467.
  • 6Birkeland SA. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients [J].Transplantation ,2001,71 (8): 1089 - 1090.
  • 7Danovitch GM. Immunosuppresant-induced metabolic toxicities [J]. Transplant Rev, 2000,14 (2): 65 - 81.
  • 8Shah MB, Martin JE,Schroeder TJ, et al. The evaluation of the safety and tolerability of two formulation of cyclosporine neural and sandimmun [J]. Transplantation, 1999, 67 ( 11 ): 1411 - 1417.

同被引文献100

引证文献16

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部